{"id":8275,"date":"2023-03-21T12:15:11","date_gmt":"2023-03-21T10:15:11","guid":{"rendered":"https:\/\/www.norameda.com\/norameda-specializeto-zalu-nodalas-vaditaja-cina-par-dzivibu-ir-visneatlaidigaka\/"},"modified":"2023-03-21T12:15:11","modified_gmt":"2023-03-21T10:15:11","slug":"norameda-specializeto-zalu-nodalas-vaditaja-cina-par-dzivibu-ir-visneatlaidigaka","status":"publish","type":"post","link":"https:\/\/www.norameda.com\/lv\/norameda-specializeto-zalu-nodalas-vaditaja-cina-par-dzivibu-ir-visneatlaidigaka\/","title":{"rendered":"\u201cNorameda\u201d specializ\u0113to z\u0101\u013cu noda\u013cas vad\u012bt\u0101ja: \u201cC\u012b\u0146a par dz\u012bv\u012bbu ir visneatlaid\u012bg\u0101k\u0101\u201d"},"content":{"rendered":"<p style=\"font-weight: 400;\">\u0160ogad, t\u0101pat k\u0101 katra gada s\u0101kum\u0101, ir ierasts atskat\u012bties uz aizvad\u012bto gadu un ieskic\u0113t n\u0101kotnes ieceres, t\u0101d\u0113\u013c ar savu redz\u0113jumu dal\u012bj\u0101s Sandra Ivanaus\u0137iene <em>(Sandra Ivanauskien\u0117)\u00a0<\/em>\u2013 \u201cNorameda\u201d specializ\u0113to z\u0101\u013cu noda\u013cas dibin\u0101t\u0101ja un vad\u012bt\u0101ja: \u201cM\u016bsu noda\u013ca turpina veiksm\u012bgu gadu ciklu. 2022.\u00a0gads bija labs gads, jo pieauga p\u0101rdo\u0161anas apjomi, kolekt\u012bvam pievienoj\u0101s jauni, sp\u0113j\u012bgi cilv\u0113ki un, galvenais\u00a0\u2013 jaun\u0101k\u0101s \u0101rst\u0113\u0161anas iesp\u0113jas, kuras uz\u0146\u0113mums var\u0113ja sniegt Lietuvas pacientiem.\u201d<\/p>\n<h3 style=\"font-weight: 400;\"><strong>Jaunas z\u0101les pacientiem ar ret\u0101m slim\u012bb\u0101m<\/strong><\/h3>\n<p style=\"font-weight: 400;\">Speci\u0101lo z\u0101\u013cu noda\u013cas vad\u012bt\u0101ja ir \u013coti gandar\u012bta, ka, pateicoties vi\u0146as komandas centieniem, pacienti ar ret\u0101m slim\u012bb\u0101m ir sa\u0146\u0113mu\u0161i nepiecie\u0161amo \u0101rst\u0113\u0161anu, sp\u0113ju\u0161i iev\u0113rot tiem piem\u0113roto \u0101rst\u0113\u0161anas re\u017e\u012bmu un t\u0101d\u0113j\u0101di vismaz mazin\u0101t slim\u012bbas slogu\u00a0\u2013 pagaid\u0101m tikai 5\u00a0procenti reto slim\u012bbu var tikt \u0101rst\u0113tas.<\/p>\n<p>2022. gad\u0101 p\u0101r\u0146emot \u201cLaber\u201d neirop\u0101tijas \u0101rst\u0113\u0161anas z\u0101\u013cu p\u0101rst\u0101vniec\u012bbu, S.\u00a0Ivanaus\u0137ienes noda\u013ca sekm\u012bgi ien\u0101ca oftalmolo\u0123ijas jom\u0101: \u201cP\u0113c ien\u0101k\u0161anas \u0161aj\u0101 uz\u0146\u0113mumam jaunaj\u0101 darb\u012bbas jom\u0101, pateicoties l\u012bdz\u0161in\u0113jai pieredzei, esam k\u013cuvu\u0161i par uzticamiem partneriem un l\u012bdzgaitniekiem\u201d.<\/p>\n<p style=\"font-weight: 400;\">Turkl\u0101t pag\u0101ju\u0161aj\u0101 gad\u0101 \u201cNorameda\u201d Lietuvas tirgu iepaz\u012bstin\u0101ja ar jaun\u0101m Parkinsona slim\u012bbas \u0101rst\u0113\u0161anai paredz\u0113t\u0101m z\u0101l\u0113m. Uz\u0146\u0113mums ir vien\u012bgais Baltijas valst\u012bs un kaimi\u0146valst\u012bs, kas sniedz \u0161o unik\u0101lo \u0101rst\u0113\u0161anas iesp\u0113ju.<\/p>\n<p style=\"font-weight: 400;\">\u201cLai gan \u0161is jaunais Parkinsona slim\u012bbu \u0101rst\u0113jo\u0161ais medikaments netiek kompens\u0113ts, pozit\u012bvi ir tas, ka pacientiem vismaz ir pieejama \u0161\u012b terapija. Dar\u012bj\u0101m visu iesp\u0113jamo, lai izplat\u012btu inform\u0101ciju: t\u0101 sasniedza daudzus pacientus, un mums izdev\u0101s sasniegt lieliskus rezult\u0101tus: da\u013ca pacientu jau ce\u013cas no gultas,\u201d st\u0101sta S.\u00a0Ivanaus\u0137iene.<\/p>\n<h3 style=\"font-weight: 400;\"><strong>Kar\u0161 Ukrain\u0101 ir sk\u0101ris ikvienu <\/strong><\/h3>\n<p style=\"font-weight: 400;\">\u201cTom\u0113r 2022.\u00a0gads bija v\u0113l sare\u017e\u0123\u012bt\u0101ks par iepriek\u0161\u0113jo, ko iez\u012bm\u0113ja Covid-19 pand\u0113mijas laiks,\u201d vi\u0146a bilst. Kar\u0161 Ukrain\u0101, lai ar\u012b netie\u0161i, ir sk\u0101ris ikvienu cilv\u0113ku un ikvienu darb\u012bbas jomu: \u201cM\u0113s nebij\u0101m iz\u0146\u0113mums. \u0160ie sirdi ploso\u0161ie notikumi ir liku\u0161i mums saprast, ka farmaceitisk\u0101 darb\u012bba ir notur\u012bga un stabila, jo c\u012b\u0146a par dz\u012bv\u012bbu ir visneatlaid\u012bg\u0101k\u0101,\u201d saka S.\u00a0Ivanaus\u0137iene.<\/p>\n<p style=\"font-weight: 400;\">\u201cNorameda\u201d noda\u013cas vad\u012bt\u0101ja uzskata, ka, neraugoties uz izaicin\u0101jumiem, uz\u0146\u0113mums ir palicis uztic\u012bgs sav\u0101m v\u0113rt\u012bb\u0101m un m\u0113r\u0137im\u00a0\u2013 rast l\u012bdzsvaru starp pe\u013c\u0146u un kalpo\u0161anu cilv\u0113kiem.<\/p>\n<p style=\"font-weight: 400;\">\u201cM\u0113s turpin\u0101m pa\u013cauties uz savlaic\u012bgas un korektas komunik\u0101cijas principu, tas \u013cauj noskaidrot, atkl\u0101t un p\u0113c tam risin\u0101t visas probl\u0113mas un izaicin\u0101jumus, kas saist\u012bti ar slim\u012bbas sloga mazin\u0101\u0161anu,\u201d apgalvo S.\u00a0Ivanaus\u0137iene.<\/p>\n<h3 style=\"font-weight: 400;\"><strong>Jauns gads\u00a0\u2013 jaunas iesp\u0113jas<\/strong><\/h3>\n<p>2023. gads ir jaunu iesp\u0113ju gads, kas pras\u012bs jaunus risin\u0101jumus: tiek \u012bstenots pl\u0101ns par F\u0101bri slim\u012bbas \u0101rst\u0113\u0161anas veida pied\u0101v\u0101jumu Lietuvas tirgum, b\u016bs v\u0113l viens jauns medikaments reto slim\u012bbu \u0101rst\u0113\u0161anai.<\/p>\n<p style=\"font-weight: 400;\">\u201cTurkl\u0101t m\u0113s papla\u0161in\u0101m savu pied\u0101v\u0101jumu ar\u012b neirolo\u0123ijas jom\u0101, esam noz\u012bm\u012bgi partneri neonatolo\u0123ij\u0101. Esmu stingri p\u0101rliecin\u0101ta par to, ka, pateicoties m\u016bsu pieredzei, visi izaicin\u0101jumi beidzot p\u0101rtaps par jaun\u0101m iesp\u0113j\u0101m gan m\u016bsu pacientiem, gan m\u016bsu uz\u0146\u0113mumam,\u201d\u00a0\u2013 par gaid\u0101mo gadu saka S.\u00a0Ivanaus\u0137iene.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0160ogad, t\u0101pat k\u0101 katra gada s\u0101kum\u0101, ir ierasts atskat\u012bties uz aizvad\u012bto gadu un ieskic\u0113t n\u0101kotnes ieceres, t\u0101d\u0113\u013c ar savu redz\u0113jumu dal\u012bj\u0101s Sandra Ivanaus\u0137iene (Sandra Ivanauskien\u0117)\u00a0\u2013 \u201cNorameda\u201d specializ\u0113to z\u0101\u013cu noda\u013cas dibin\u0101t\u0101ja un vad\u012bt\u0101ja: \u201cM\u016bsu noda\u013ca turpina veiksm\u012bgu gadu ciklu. 2022.\u00a0gads bija labs gads, jo pieauga p\u0101rdo\u0161anas apjomi, kolekt\u012bvam pievienoj\u0101s jauni, sp\u0113j\u012bgi cilv\u0113ki un, galvenais\u00a0\u2013 jaun\u0101k\u0101s \u0101rst\u0113\u0161anas [&hellip;]<\/p>\n","protected":false},"author":220,"featured_media":8182,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_links_to":"","_links_to_target":""},"categories":[141],"tags":[],"_links":{"self":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/8275"}],"collection":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/users\/220"}],"replies":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/comments?post=8275"}],"version-history":[{"count":0,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/8275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media\/8182"}],"wp:attachment":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media?parent=8275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/categories?post=8275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/tags?post=8275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}